Health Canada reviewing safety of drug Rasilez after patient trial halted

OTTAWA - Health Canada is reviewing the safety of the blood-pressure drug Rasilez after its manufacturer halted a large study that showed the medication could have adverse effects when combined with some other prescription drugs....More